Spontaneous Bacterial Peritonitis
41
3
3
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.9%
2 terminated out of 41 trials
88.9%
+2.4% vs benchmark
37%
15 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (41)
Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
Predicting and Monitoring Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using the Mansoura Scoring System
Prediction of SBP in Cirrhotic Patients by Platlet Count, Na and AlBl Index.
Comparative Study of Secondary Prophylaxis for SBP
Frequency and Predictors of Recurrent SBP in Cirrhotic Patients in Al Rajhi University Hospital
Early Ascitis Parencentesis in SBP
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis
Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin
Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial)
Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis
Laboratory Diagnosis of Spontaneous Bacterial Peritonitis
MPV and NLR as Predictors of SBP Diagnosis
Ascitic Fluid Calprotectin as an Accurate Diagnostic Marker for Spontaneous Bacterial Peritonitis
Meropenem vs Cefotaxime as Empirical Treatment of SBP
Serum Copeptin in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.
Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis
A Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF for the Management of Spontaneous Bacterial Peritonitis Presenting With Septic Shock.
Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis
Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis